Stay updated on Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.

Latest updates to the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows Revision: v3.3.2 in the footer replacing the previous v3.3.1, with no other visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedA new revision entry v3.3.1 was added to the history and the prior v3.2.0 entry was removed. This is an administrative update with no impact on the study information.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page removed the top-level notice about a lapse in government funding and potential updates being delayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe new screenshot shows a minor change in the Record History page appearance, with no alteration to study data or essential sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference5%

- Check79 days agoChange DetectedUpdate to a newer software version (from v3.0.2 to v3.1.0); the page now reflects the latest revision identifier.SummaryDifference0.1%

Stay in the know with updates to Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.